Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNA5 | P22460 | 1/20 | 0.50 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.49 |
| ▸ | KCNK9 | Q9NPC2 | 1/20 | 0.49 |
| ▸ | PGAM1 | P18669 | 1/20 | 0.48 |
| ▸ | MRGPRX1 | Q96LB2 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11043836 | 0.94 | — | — | |
| SCHEMBL10646481 | 0.94 | — | — | |
| SCHEMBL27919527 | 0.91 | KCNA5 (0.59) | KCNA5KCNK3 | |
| SCHEMBL13743071 | 0.87 | — | — | |
| SCHEMBL10434954 | 0.85 | KCNA5 (0.50) | KCNA5KCNK3KCNK9PGAM1MRGPRX1 | |
| SCHEMBL25219425 | 0.84 | CYP1A2 (0.56) | KCNA5KCNK3KCNK9MRGPRX1 | |
| SCHEMBL11667006 | 0.84 | — | — | |
| SCHEMBL8609056 | 0.82 | — | — | |
| SCHEMBL12201484 | 0.82 | MRGPRX1 (0.50) | MRGPRX1 | |
| SCHEMBL12200974 | 0.82 | MRGPRX1 (0.50) | MRGPRX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080081926-A1 | SULFONYLAMINOBENZOIC ACID AND SALT | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2008-04-03 | — | — | US | disclosed |
| US-20080081926-A1 | SULFONYLAMINOBENZOIC ACID AND SALT | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2008-04-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080081926-A1 | SULFONYLAMINOBENZOIC ACID AND SALT | SLC5A1, SLC5A2, SLC1A5 | KCNA5 119/4885KCNK3 842/4885KCNK9 774/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.